NM_000074.3:c.410-13T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000074.3(CD40LG):​c.410-13T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.13 in 1,206,594 control chromosomes in the GnomAD database, including 15,267 homozygotes. There are 50,475 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 5848 hom., 8327 hem., cov: 22)
Exomes 𝑓: 0.12 ( 9419 hom. 42148 hem. )

Consequence

CD40LG
NM_000074.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.331

Publications

17 publications found
Variant links:
Genes affected
CD40LG (HGNC:11935): (CD40 ligand) The protein encoded by this gene is expressed on the surface of T cells. It regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper-IgM syndrome. [provided by RefSeq, Jul 2008]
CD40LG Gene-Disease associations (from GenCC):
  • hyper-IgM syndrome type 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant X-136659026-T-C is Benign according to our data. Variant chrX-136659026-T-C is described in ClinVar as Benign. ClinVar VariationId is 518407.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.689 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD40LGNM_000074.3 linkc.410-13T>C intron_variant Intron 4 of 4 ENST00000370629.7 NP_000065.1 P29965

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD40LGENST00000370629.7 linkc.410-13T>C intron_variant Intron 4 of 4 1 NM_000074.3 ENSP00000359663.2 P29965

Frequencies

GnomAD3 genomes
AF:
0.267
AC:
29594
AN:
110768
Hom.:
5844
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.697
Gnomad AMI
AF:
0.00438
Gnomad AMR
AF:
0.178
Gnomad ASJ
AF:
0.138
Gnomad EAS
AF:
0.101
Gnomad SAS
AF:
0.225
Gnomad FIN
AF:
0.0652
Gnomad MID
AF:
0.228
Gnomad NFE
AF:
0.0858
Gnomad OTH
AF:
0.240
GnomAD2 exomes
AF:
0.167
AC:
30241
AN:
181473
AF XY:
0.156
show subpopulations
Gnomad AFR exome
AF:
0.715
Gnomad AMR exome
AF:
0.180
Gnomad ASJ exome
AF:
0.128
Gnomad EAS exome
AF:
0.104
Gnomad FIN exome
AF:
0.0745
Gnomad NFE exome
AF:
0.0901
Gnomad OTH exome
AF:
0.154
GnomAD4 exome
AF:
0.116
AC:
126805
AN:
1095772
Hom.:
9419
Cov.:
30
AF XY:
0.117
AC XY:
42148
AN XY:
361532
show subpopulations
African (AFR)
AF:
0.726
AC:
19119
AN:
26331
American (AMR)
AF:
0.182
AC:
6410
AN:
35197
Ashkenazi Jewish (ASJ)
AF:
0.128
AC:
2469
AN:
19362
East Asian (EAS)
AF:
0.116
AC:
3501
AN:
30199
South Asian (SAS)
AF:
0.234
AC:
12646
AN:
54086
European-Finnish (FIN)
AF:
0.0755
AC:
3045
AN:
40339
Middle Eastern (MID)
AF:
0.229
AC:
943
AN:
4126
European-Non Finnish (NFE)
AF:
0.0852
AC:
71601
AN:
840115
Other (OTH)
AF:
0.154
AC:
7071
AN:
46017
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
3405
6810
10216
13621
17026
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3054
6108
9162
12216
15270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.268
AC:
29654
AN:
110822
Hom.:
5848
Cov.:
22
AF XY:
0.250
AC XY:
8327
AN XY:
33360
show subpopulations
African (AFR)
AF:
0.697
AC:
21124
AN:
30312
American (AMR)
AF:
0.178
AC:
1868
AN:
10503
Ashkenazi Jewish (ASJ)
AF:
0.138
AC:
364
AN:
2633
East Asian (EAS)
AF:
0.101
AC:
359
AN:
3542
South Asian (SAS)
AF:
0.226
AC:
596
AN:
2641
European-Finnish (FIN)
AF:
0.0652
AC:
393
AN:
6023
Middle Eastern (MID)
AF:
0.241
AC:
51
AN:
212
European-Non Finnish (NFE)
AF:
0.0858
AC:
4526
AN:
52756
Other (OTH)
AF:
0.244
AC:
370
AN:
1515
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
519
1038
1556
2075
2594
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.187
Hom.:
2122
Bravo
AF:
0.298

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hyper-IgM syndrome type 1 Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 21% of patients studied by a panel of primary immunodeficiencies. Number of patients: 20. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.1
DANN
Benign
0.48
PhyloP100
-0.33
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3092923; hg19: chrX-135741185; COSMIC: COSV65698579; API